X0508 4 2023-10-03 0 0001438533 Travere Therapeutics, Inc. TVTX 0001789617 Heerma Peter C/O TRAVERE THERAPEUTICS, INC. 3611 VALLEY CENTRE DRIVE, SUITE 300 SAN DIEGO CA 92130 0 1 0 0 Chief Commercial Officer 0 Common Stock 2023-10-03 4 S 0 3091 8.2511 D 80257 D Represents the number of shares required to be sold by the Reporting Person to cover the tax withholding obligation in connection with the settlement of vested restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the Reporting Person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the Reporting Person. Includes 1,279 shares of the Issuer's common stock acquired by the reporting person on May 31, 2023 pursuant to an employee stock purchase program. /s/ Elizabeth E. Reed, Attorney-in-Fact 2023-10-04